Neolab Limited Raises £2M

Neolab Limited, an Odiham, UK-based generic pharmaceutical business, has received a £2m investment from Maven Capital Partners as joint manager of the Government backed Capital for Enterprise Fund.
The investment will enable the company to continue its expansion and realise the significant potential from its pipeline of new products.
Founded in 1999, Neolab specialises in the licensing, registration and marketing of generic medicines, with a particular focus on products for the treatment of respiratory diseases.

Join the discussion